At Medlab Clinical Ltd (Medlab), we believe we have the fundamentals to "create". Where innovative thinking thrives and research is valued. We have created a culture that we are proud of.
Medlab has an outstanding research portfolio in early phase drug discovery across obesity, chronic kidney disease, depression, muscular loss associated with ageing and non opioid pain management.
Our facility is an approved Office of the Gene Technology Regulator (OGTR), Physical Containment level-2 (PC2) biological laboratory, the main stage for our research focus.
From our research portfolio, novel nutraceuticals are designed for specific clinical needs.
Our core principles are:
This allows us to encapsulate the true meaning of translational research and focus on specific milestones to move from "bench" to "bedside."